AcceGen

AcceGen developed significant expertise in cell and genomic research.🧫🧬

[AcceGen @accegen]

🚀 Power your research with 4,000+ cell products—from human primary cells to iPSCs, tumor lines & exosomes.
Need custom CAR-T cells, CRISPR knockouts, or miRNA synthesis? We’ve got your back.
🔬 Trusted in 40+ countries.
https://t.co/aWikcjKT1u

#Biotech #iPSC #GeneEditing

[AcceGen @accegen]

Cell freezing doesn’t have to be complicated ❄️

AcceGen One-Step Freezing Medium is designed to support cell integrity and post-thaw recovery 📈 (often >90%*, depending on cell type and conditions).

🎁 Buy 1 Get 1 FREE
🎁 Free 50 mL with selected cell lines

[AcceGen @accegen]

Meet HT-29, a trusted model for colorectal cancer and intestinal research.
It forms polarized epithelial layers with tight junctions & microvilli, ideal for
🔹 Drug absorption assays
🔹 Microbiome studies
🔹 3D tumor models

https://t.co/RRAPzsbyC2

#HT29 #AcceGen #CancerResearch

[AcceGen @accegen]

Hyperparathyroidism disrupts calcium balance, causing serious symptoms. While surgery is key, research is vital for future advances.

AcceGen provides critical research tools to help scientists study PTH regulation and tumor biology.

Explore more: https://t.co/nzfbTytWHa

#PTH

[AcceGen @accegen]

Needle-free vaccines by stretching the skin! 💡
New study: skin stretch opens hair follicles, boosts immune response, & outperforms injections.

At AcceGen, we see big potential for patient-friendly biologics delivery.
🔗 https://t.co/3YISp2Wp1D

#Vaccine #DrugDelivery #AcceGen

[AcceGen @accegen]

🔬
SH-SY5Y is a versatile human neuroblastoma cell line, widely used in Alzheimer’s, Parkinson’s & neurotoxicity research.
A trusted model for neuronal differentiation & drug discovery.

https://t.co/2K1y217dyl

#Neuroscience #CellBiology #DrugDiscovery

[AcceGen @accegen]

NB-4 Cells — the gold-standard model for APL research.
Right after receiving their order, a leading global biopharma client shared this feedback:
"Yes, I received the package yesterday. I appreciate your help and support!"
https://t.co/Sxm2mfxteW

##CellBiology #DrugDiscovery

[AcceGen @accegen]

OA treatment is evolving! 💡 Exosomes are breakthrough nanoscale tools targeting the root cause of osteoarthritis, reducing inflammation & promote cartilage repair.

Learn how AcceGen is powering this RegenerativeMedicine revolution. 👇

#Exosomes #Osteoarthritis

[AcceGen @accegen]

🔬 IHC tip: Don’t skip antigen retrieval! Heat or enzymes unmask epitopes so antibodies bind better.
More research tools: https://t.co/3YISp2VRc5
#AcceGen #IHC #LabTips #BiotechCareers

[AcceGen @accegen]

Neuroscience is back in the spotlight!

Ion channels are offering fresh hope for non-opioid treatments. Pair that with cryo-EM, organ-on-chip, and AI, and the next era of brain therapeutics is emerging.
@AcceGen, we aim to accelerate this transformation.

#Neuroscience #Biotech

[AcceGen @accegen]

🔬 U937 is a classic human monocytic cell line used in immunology, oncology, & drug screening.

From NF-κB signaling to host–pathogen studies, it’s a trusted model for advancing biomedical research.

Explore U937 products https://t.co/EddYRchL9q

#CellBiology #Immunology

[AcceGen @accegen]

AcceGen’s iPSCs, dopaminergic neuron, & astrocyte lines help model disease, study dopaminergic pathways, & test therapies to reduce neuroinflammation—bringing hope for longer Parkinson’s disease life expectancy. https://t.co/Uk5u0SKW6m

#ParkinsonsDisease #iPSCs #NeuroResearch

[AcceGen @accegen]

Our Human Liver Sinusoidal Endothelial Cells are vital for liver microvascular biology, drug metabolism, and hepatotoxicity research.

👉 https://t.co/VmgzEh6ML8

#AcceGen #LiverCells #BiomedicalResearch #LifeScience

[AcceGen @accegen]

⚙️ Centrifugation = essential for clean preps & consistent results.

🔬 Tip: Balance your tubes + match the RCF to your sample.
At #AcceGen, our products are centrifuge-ready for workflows in RNA, protein & EV research.
🔗 https://t.co/zB7C6T76bL

#LabTips #Centrifugation #Bio

[AcceGen @accegen]

🚀 FDA approves Brinsupri (brensocatib) — the first treatment for non-CF bronchiectasis!

A brand-new DPP1 inhibitor class now brings hope to patients with this chronic lung disease.

At @AcceGen, we celebrate breakthroughs that redefine science and care.

#Biotech #DrugApproval

[AcceGen @accegen]

CHO cells are reshaping vaccine manufacturing: human-like PTMs, serum-free high-density growth, strong yields.
Four FDA-approved vaccines now use CHO-derived antigens (RSV, HBV, shingles).
Read more + explore products: https://t.co/j1XbSsUZIE

#CHOcells #Vaccines #Biotech

[AcceGen @accegen]

PBMCs are shaping the future of #immunology, #oncology & #vaccine research.
AcceGen delivers human & animal PBMCs — healthy & disease-state, high-quality, reproducible, and ready for cutting-edge studies.
🔗 Learn more: https://t.co/J5JTgDje2X
#PBMC #CellTherapy #Biotech

[AcceGen @accegen]

A leading European stem cell research service provider shared their experience with AcceGen:
At AcceGen, we’re proud to deliver reliable products and outstanding support that empower research worldwide.
Purchase the same product here: https://t.co/FUNTTTzMsz
#AcceGen #StemCells

[AcceGen @accegen]

⚡ Still a classic: Gel electrophoresis is key for DNA, RNA, and protein separation.
🔬 Tip: Use fresh buffer + proper loading = cleaner bands.
At #AcceGen, products are optimized for clean, reproducible results.
🔗 https://t.co/zB7C6T76bL
#Electrophoresis #LabTips #LifeScience

[AcceGen @accegen]

FDA approves prefilled syringe version of Shingrix—no more reconstitution needed.
AcceGen’s immune cell platforms support safer, faster vaccine development. From dendritic cells to co-cultures, we fuel immunology innovation. 💉🧬 #Vaccines #Immunology #Shingrix #iPSC #Biotech

[AcceGen @accegen]

🔬 THP-1 cells, from acute monocytic leukemia, retain monocyte traits and can differentiate into macrophage-like cells with PMA.
Used for NF-κB/TLR signaling, cytokine studies, infection models & drug screening 💊.
https://t.co/FbPt7J8HCA
#Immunology #Oncology #DrugDiscovery